The recognition of viral peptides in the context of MHCI proteins by cytotoxic T lymphocytes is a key event for eliminating virus-infected cells. Prior to presenting peptides at the cell surface, MHCI proteins must undergo a stringent maturation process in the lumen of the endoplasmic reticulum by transiently interacting with members of the peptide loading complex (PLC). After dissociation from the PLC, peptide-bound MHCI proteins transit through the Golgi to the surface following the secretory pathway. The secretory pathway is known to involve a series of membrane bound compartments with specialized functions in cargo transport;however, many of the molecular details of this pathway have yet to be elucidated. To resolve outstanding questions of MHCI biosynthesis along the secretory pathway, we will use viral immune evasion proteins as probes for physiologic pathways. Viruses encode a plethora of immune evasion proteins that exploit a surprising diversity of physiologic pathways to block antigen presentation and they do so with great specificity and potency. These properties make immune evasion proteins highly effective probes for defining molecular pathways of protein quality control that are of particular relevance to MHCI function. In this grant, we will use immune evasion proteins to probe i) how misfolded MHCI proteins are identified and translocated from the ER lumen to the cytosol, ii) mechanisms of ER to Golgi recycling and their importance for MHC quality control and initiating ERAD, and iii) the physiologic role of ubiquitination of lysine vs. serine MHCI residues for ERAD and recycling from the plasma membrane. The proposed experiments will use cell biological, biochemical, and structural approaches employed by collaborative efforts of the Hansen and Fremont labs.
Viruses express proteins that block their detection by immune cells of the host. Furthermore, these viral immune evasion proteins efficiently exploit physiologic pathways, thus making them highly effective probes for molecular dissection of mechanisms of pathogen recognition by immune cells. Experiments in this grant will define the mechanisms used by several different herpesvirus or poxvirus immune evasion proteins to target host proteins and thereby block specific cellular pathways of critical importance for pathogen detection.
|Ghasemi, Reza; Lazear, Eric; Wang, Xiaoli et al. (2016) Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy. Nat Commun 7:12878|
|Lubman, Olga Y; Fremont, Daved H (2016) Parallel Evolution of Chemokine Binding by Structurally Related Herpesvirus Decoy Receptors. Structure 24:57-69|
|Nelson, Christopher A; Epperson, Megan L; Singh, Sukrit et al. (2015) Structural Conservation and Functional Diversity of the Poxvirus Immune Evasion (PIE) Domain Superfamily. Viruses 7:4878-98|
|Kim, Sojung; Pinto, Amelia K; Myers, Nancy B et al. (2014) A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice. Eur J Immunol 44:1936-46|
|Lubman, Olga Y; Cella, Marina; Wang, Xinxin et al. (2014) Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor. J Virol 88:538-46|
|McCoy 4th, William H; Wang, Xiaoli; Yokoyama, Wayne M et al. (2013) Cowpox virus employs a two-pronged strategy to outflank MHCI antigen presentation. Mol Immunol 55:156-8|
|Wang, Xiaoli; Yu, Y Y Lawrence; Myers, Nancy et al. (2013) Decoupling the role of ubiquitination for the dislocation versus degradation of major histocompatibility complex (MHC) class I proteins during endoplasmic reticulum-associated degradation (ERAD). J Biol Chem 288:23295-306|
|Mage, Michael G; Dolan, Michael A; Wang, Rui et al. (2013) A structural and molecular dynamics approach to understanding the peptide-receptive transition state of MHC-I molecules. Mol Immunol 55:123-5|
|Lazear, Eric; Peterson, Lance W; Nelson, Chris A et al. (2013) Crystal structure of the cowpox virus-encoded NKG2D ligand OMCP. J Virol 87:840-50|
|Mage, Michael G; Dolan, Michael A; Wang, Rui et al. (2012) The peptide-receptive transition state of MHC class I molecules: insight from structure and molecular dynamics. J Immunol 189:1391-9|
Showing the most recent 10 out of 74 publications